— Know what they know.
Not Investment Advice

069620.KS KSC

Daewoong pharmaceutical Co.,Ltd
1W: +2.6% 1M: -14.0% 3M: -7.9% YTD: -39.1% 1Y: -18.7% 3Y: +13.3% 5Y: -37.1%
₩109,000.00 ($81.19)
-600.00 (-0.55%)
 
Weekly Expected Move ±4.8%
₩98556 ₩103778 ₩109000 ₩114222 ₩119444
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 31 · ₩1.25T mcap · 4M float · 0.802% daily turnover
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₩1.25T ($934.2M)
52W Range104900-199400
Volume15,122
Avg Volume34,926
Beta0.01
Dividend₩600.00
Analyst Ratings
No analyst coverage
Company Info
CEOChang-Jae Lee
Employees1,794
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2005-09-29
12, Bongeunsa-ro 114-gil
Seoul, GY 135-715
KR
82 2 550 8209
About Daewoong pharmaceutical Co.,Ltd

Established in 1945 and headquartered in Seoul, South Korea, Daewoong Pharmaceutical Co., Ltd. is a global entity dedicated to the research, production, and international distribution of a diverse range of pharmaceutical products. Its extensive portfolio provides therapeutic solutions across numerous health disciplines, including treatments for central nervous system disorders, endocrine conditions, musculoskeletal ailments, nephrological issues, oncology, cardiovascular diseases, gastrointestinal complaints, and metabolic dysfunctions. The company further offers products addressing viral infections, pain relief, antacids, digestive problems, wound care, and nutritional supplements such as iron and multivitamins. Complementing its pharmaceutical offerings, Daewoong also supplies medical devices, notably COVID-19 PCR and IgG/IgM RDT diagnostic kits, along with viral transport media.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms